Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Lang, Susan M ^a   Kazi, Abid A ^a   Hong Brown, Ly ^a   Lang, Charles H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; CD45 ANTIGEN; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; PROTEASOME; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RESPONSE; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; IMMOBILIZATION; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE GROWTH; MUSCLE LEVEL; MUSCLE MASS; MYOSITIS; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN SYNTHESIS REGULATION; WILD TYPE;

ANIMALS; ANTIGENS, CD45; HETEROZYGOTE; HINDLIMB SUSPENSION; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862660964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038910     Document Type: Article

References (80)

1. Frost RA, Lang CH, (2007) Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol 103: 378-387.
2. Hood DA, Irrcher I, Ljubicic V, Joseph AM, (2006) Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 209: 2265-2275.
3. Evans WJ, (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91: 1123S-1127S.
4. Fitts RH, Romatowski JG, Peters JR, Paddon-Jones D, Wolfe RR, et al. (2007) The deleterious effects of bed rest on human skeletal muscle fibers are exacerbated by hypercortisolemia and ameliorated by dietary supplementation. Am J Physiol Cell Physiol 293: C313-C320.
5. Gibson JN, Halliday D, Morrison WL, Stoward PJ, Hornsby GA, et al. (1987) Decrease in human quadriceps muscle protein turnover consequent upon leg immobilization. Clin Sci (Lond) 72: 503-509.
6. Gustafsson T, Osterlund T, Flanagan JN, von Waldén, Trappe TA, et al. (2010) Effects of 3 days unloading on molecular regulators of muscle size in humans. J Appl Physiol 109: 721-727.
7. Kim SJ, Roy RR, Zhong H, Suzuki H, Ambartsumyan L, et al. (2007) Electromechanical stimulation ameliorates inactivity-induced adaptations in the medial gastrocnemius of adult rats. J Appl Physiol 103: 195-205.
8. Krawiec BJ, Frost RA, Vary TC, Jefferson LS, Lang CH, (2005) Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab 289: E969-E980.
9. LeMoine JK, Haus JM, Trappe SW, Trappe TA, (2009) Muscle proteins during 60-day bedrest in women: impact of exercise or nutrition. Muscle Nerve 39: 463-471.
10. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708.
11. Booth FW, Seider MJ, (1979) Early change in skeletal muscle protein synthesis after limb immobilization of rats. J Appl Physiol 47: 974-977.
12. Kazi AA, Hong-Brown L, Lang SM, Lang CH, (2011) Deptor knockdown enhances mTOR Activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy. Mol Med 17: 925-936.
13. Vazeille E, Codran A, Claustre A, Averous J, Listrat A, et al. (2008) The ubiquitin-proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy. Am J Physiol Endocrinol Metab 295: E1181-E1190.
14. Glover EI, Phillips SM, Oates BR, Tang JE, Tarnopolsky MA, et al. (2008) Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion. J Physiol 586: 6049-6061.
15. Stelzer JE, Widrick JJ, (2003) Effect of hindlimb suspension on the functional properties of slow and fast soleus fibers from three strains of mice. J Appl Physiol 95: 2425-2433.
16. Stevens-Lapsley JE, Ye F, Liu M, Borst SE, Conover C, et al. (2010) Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilization. Am J Physiol Endocrinol Metab 299: E730-E740.
17. Frost RA, Lang CH, (2011) mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology (Bethesda) 26: 83-96.
18. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, et al. (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019.
19. Burks TN, Andres-Mateos E, Marx R, Mejias R, Van EC, et al. (2011) Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med 3: 82ra37.
20. Childs TE, Spangenburg EE, Vyas DR, Booth FW, (2003) Temporal alterations in protein signaling cascades during recovery from muscle atrophy. Am J Physiol Cell Physiol 285: C391-C398.
21. Haddad F, Roy RR, Zhong H, Edgerton VR, Baldwin KM, (2003) Atrophy responses to muscle inactivity. II. Molecular markers of protein deficits. J Appl Physiol 95: 791-802.
22. Murton AJ, Constantin D, Greenhaff PL, (2008) The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 1782: 730-743.
23. Risson V, Mazelin L, Roceri M, Sanchez H, Moncollin V, et al. (2009) Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol 187: 859-874.
24. Gangloff YG, Mueller M, Dann SG, Svoboda P, Sticker M, et al. (2004) Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 24: 9508-9516.
25. Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K, et al. (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24: 6710-6718.
26. Lang CH, Frost RA, Bronson SK, Lynch CJ, Vary TC, (2010) Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine. Am J Physiol Endocrinol Metab 298: E1283-E1294.
27. Magne H, Savary-Auzeloux I, Vazeille E, Claustre A, Attaix D, et al. (2011) Lack of muscle recovery after immobilization in old rats does not result from a defect in normalization of the ubiquitin-proteasome and the caspase-dependent apoptotic pathways. J Physiol 589: 511-524.
28. Vargas R, Lang CH, (2008) Alcohol accelerates loss of muscle and impairs recovery of muscle mass resulting from disuse atrophy. Alcohol Clin Exp Res 32: 128-137.
29. Vary TC, Lang CH, (2008) Assessing effects of alcohol consumption on protein synthesis in striated muscles. Methods Mol Biol 447: 343-355.
30. Lang CH, Frost RA, Nairn AC, MacLean DA, Vary TC, (2002) TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 282: E336-E347.
31. Garlick PJ, McNurlan MA, Essen P, Wernerman J, (1994) Measurement of tissue protein synthesis rates in vivo: a critical analysis of contrasting methods. Am J Physiol 266: E287-E297.
32. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
33. Foletta VC, White LJ, Larsen AE, Leger B, Russell AP, (2011) The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch 461: 325-335.
34. Frost RA, Nystrom GJ, Jefferson LS, Lang CH, (2007) Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Am J Physiol Endocrinol Metab 292: E501-E512.
35. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL, (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98: 14440-14445.
36. Vary TC, Frost RA, Lang CH, (2008) Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 294: R1777-R1789.
37. Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, et al. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332: 1322-1326.
38. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175.
39. Dogra C, Changotra H, Wedhas N, Qin X, Wergedal JE, et al. (2007) TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 21: 1857-1869.
40. Li H, Malhotra S, Kumar A, (2008) Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl) 86: 1113-1126.
41. Peterson JM, Feeback KD, Baas JH, Pizza FX, (2006) Tumor necrosis factor-alpha promotes the accumulation of neutrophils and macrophages in skeletal muscle. J Appl Physiol 101: 1394-1399.
42. Frost RA, Lang CH, (2003) Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells. Minerva Endocrinol 28: 53-73.
43. Flueck M, Goldspink G, (2010) Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Counterpoint: IGF is not the major physiological regulator of muscle mass. J Appl Physiol 108: 1821-1823.
44. Stewart CE, Pell JM, (2010) Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Point: IGF is the major physiological regulator of muscle mass. J Appl Physiol 108: 1820-1821.
45. Machida S, Booth FW, (2004) Regrowth of skeletal muscle atrophied from inactivity. Med Sci Sports Exerc 36: 52-59.
46. Bialek P, Morris C, Parkington J, St Andre M, Owens J, et al. (2011) Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy. Physiol Genomics 43: 1075-1086.
47. Caron AZ, Drouin G, Desrosiers J, Trensz F, Grenier G, (2009) A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse. J Appl Physiol 106: 2049-2059.
48. Tucker KR, Seider MJ, Booth FW, (1981) Protein synthesis rates in atrophied gastrocnemius muscles after limb immobilization. J Appl Physiol 51: 73-77.
49. Bajotto G, Sato Y, Kitaura Y, Shimomura Y, (2011) Effect of branched-chain amino acid supplementation during unloading on regulatory components of protein synthesis in atrophied soleus muscles. Eur J Appl Physiol 111: 1815-1828.
50. Murphy KT, Cobani V, Ryall JG, Ibebunjo C, Lynch GS, (2011) Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice. J Appl Physiol 110: 1065-1072.
51. Labeit S, Kohl CH, Witt CC, Labeit D, Jung J, et al. (2010) Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice. J Biomed Biotechnol 2010: 693741.
52. Abadi A, Glover EI, Isfort RJ, Raha S, Safdar A, et al. (2009) Limb immobilization induces a coordinate down-regulation of mitochondrial and other metabolic pathways in men and women. PLoS One 4: e6518.
53. Smith IJ, Lecker SH, Hasselgren PO, (2008) Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 295: E762-E771.
54. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, et al. (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483.
55. Yamamoto D, Maki T, Herningtyas EH, Ikeshita N, Shibahara H, et al. (2010) Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve 41: 819-827.
56. Lang CH, Frost RA, Vary TC, (2007) Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab 293: E453-E459.
57. Frost RA, Lang CH, (2005) Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care 8: 255-263.
58. Cai D, Frantz JD, Tawa NE, Melendez PA, Oh BC, et al. (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298.
59. Mittal A, Bhatnagar S, Kumar A, Lach-Trifilieff E, Wauters S, et al. (2010) The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol 188: 833-849.
60. Paul PK, Gupta SK, Bhatnagar S, Panguluri SK, Darnay BG, et al. (2010) Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol 191: 1395-1411.
61. Weichhart T, Saemann MD, (2008) The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 67: iii70-iii74.
62. Goldspink G, (2005) Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology (Bethesda) 20: 232-238.
63. Schakman O, Gilson H, de Coninck V, Lause P, Verniers J, et al. (2005) Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats. Endocrinology 146: 1789-1797.
64. Rabinovsky ED, Gelir E, Gelir S, Lui H, Kattash M, et al. (2003) Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J 17: 53-55.
65. Nystrom G, Pruznak A, Huber D, Frost RA, Lang CH, (2009) Local insulin-like growth factor I prevents sepsis-induced muscle atrophy. Metabolism 58: 787-797.
66. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, et al. (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27: 195-200.
67. Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, et al. (2005) Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 168: 193-199.
68. Criswell DS, Booth FW, DeMayo F, Schwartz RJ, Gordon SE, et al. (1998) Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy. Am J Physiol 275: E373-E379.
69. Barton ER, (2006) The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl Physiol Nutr Metab 31: 791-797.
70. Matheny RW, Nindl BC, Adamo ML, (2010) Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 151: 865-875.
71. Tidball JG, (2005) Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288: R345-R353.
72. Morris RT, Spangenburg EE, Booth FW, (2004) Responsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle. J Appl Physiol 96: 398-404.
73. Booth FW, (1978) Regrowth of atrophied skeletal muscle in adult rats after ending immobilization. J Appl Physiol 44: 225-230.
74. Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S, et al. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 278: 15461-15464.
75. Lang CH, Lynch CJ, Vary TC, (2010) BCATm deficiency ameliorates endotoxin-induced decrease in muscle protein synthesis and improves survival in septic mice. Am J Physiol Regul Integr Comp Physiol 299: R935-R944.
76. Holz MK, Ballif BA, Gygi SP, Blenis J, (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123: 569-580.
77. Bondesen BA, Mills ST, Pavlath GK, (2006) The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol 290: C1651-C1659.
78. Washington TA, White JP, Davis JM, Wilson LB, Lowe LL, et al. (2011) Skeletal muscle mass recovery from atrophy in IL-6 knockout mice. Acta Physiol (Oxf) 202: 657-669.
79. Sugiura T, Abe N, Nagano M, Goto K, Sakuma K, et al. (2005) Changes in PKB/Akt and calcineurin signaling during recovery in atrophied soleus muscle induced by unloading. Am J Physiol Regul Integr Comp Physiol 288: R1273-R1278.
80. Temmerman L, Slonimsky E, Rosenthal N, (2010) Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels. Growth Horm IGF Res 20: 255-263.